Reactivation of hepatitis B infection following allogeneic bone marrow transplantation in a hepatitis B-immune patient: case report and review of the literature
- PMID: 16206102
- DOI: 10.1086/496924
Reactivation of hepatitis B infection following allogeneic bone marrow transplantation in a hepatitis B-immune patient: case report and review of the literature
Abstract
Background: Reactivation of hepatitis B virus (HBV) infection following allogeneic bone marrow transplantation is a rare phenomenon.
Methods: Reverse seroconversion, defined as the clearance of antibody to hepatitis B surface antigen (HBsAb) and the appearance of hepatitis B surface antigen (HBsAg) in a patient with resolved HBV infection (i.e., a HBsAg-negative, HBsAb-positive, hepatitis B core antibody-positive patient) following receipt of a bone marrow transplant is described. A review of related cases in the literature was undertaken to identify clinical features associated with this phenomenon.
Results: We present a case of reactivation of HBV infection in a 47-year-old man after receipt of an allogeneic bone marrow transplant for acute myelogenous leukemia. Before undergoing bone marrow transplantation, the presence of HBsAb and hepatitis B core antibody and the absence of HBsAg indicated clearance of natural HBV infection. The donor was HBsAg and HBsAb negative. Twenty-nine months after bone marrow transplantation, the patient developed transaminitis and evidence of active HBV infection (the patient had test results positive for HBsAg, negative for HBsAb, and positive for HBV DNA). A total of 28 other cases of reverse seroconversion have been described in the literature, 11 of which provided adequate information to be summarized in detail together with the present case. Reactivation of HBV infection following bone marrow transplantation appears to occur almost exclusively in patients who have received marrow from an HBsAb-negative donor and have experienced graft-versus-host disease, the onset of which is associated with tapering of immunosuppressive therapy.
Conclusions: Although HBV reverse seroconversion is an uncommon event, understanding the clinical features associated with the development of HBV reverse seroconversion may provide insight into how such a potentially fatal complication may be avoided.
Comment in
-
Clinical significance of occult hepatitis B virus infection cannot be overlooked.Clin Infect Dis. 2006 Feb 15;42(4):583-4. doi: 10.1086/500016. Clin Infect Dis. 2006. PMID: 16421814 No abstract available.
Similar articles
-
Fulminant hepatitis B following bone marrow transplantation in an HBsAg-negative, HBsAb-positive recipient; reactivation of dormant virus during the immunosuppressive period.Bone Marrow Transplant. 2000 Jan;25(1):105-8. doi: 10.1038/sj.bmt.1702093. Bone Marrow Transplant. 2000. PMID: 10654023
-
Lamivudine treatment for reverse seroconversion of hepatitis B 4 years after allogeneic bone marrow transplantation.Bone Marrow Transplant. 2002 Feb;29(4):361-3. doi: 10.1038/sj.bmt.1703387. Bone Marrow Transplant. 2002. PMID: 11896435
-
Fulminant hepatitis after allogenic bone marrow transplantation caused by reactivation of hepatitis B virus with gene mutations in the core promotor region.Eur J Haematol. 2006 Sep;77(3):255-8. doi: 10.1111/j.1600-0609.2006.00678.x. Eur J Haematol. 2006. PMID: 16923112
-
Hepatitis B reactivation following allogeneic bone marrow transplantation: case report and review of the literature.Bone Marrow Transplant. 1995 Jan;15(1):145-8. Bone Marrow Transplant. 1995. PMID: 7742749 Review.
-
[Prevention and therapy of reactivation of hepatitis B in immunosuppressed patients].Dtsch Med Wochenschr. 2009 Feb;134(6):255-8. doi: 10.1055/s-0028-1123989. Epub 2009 Jan 29. Dtsch Med Wochenschr. 2009. PMID: 19180418 Review. German.
Cited by
-
Occult hepatitis B virus infection: a case of reactivation in a patient receiving immunosuppressive treatment for allogeneic bone marrow transplantation.Blood Transfus. 2008 Jan;6(1):46-50. doi: 10.2450/2008.0033-07. Blood Transfus. 2008. PMID: 18661923 Free PMC article. No abstract available.
-
Occult Hepatitis B (OBH) in Clinical Settings.Hepat Mon. 2012 Aug;12(8):e6126. doi: 10.5812/hepatmon.6126. Epub 2012 Aug 25. Hepat Mon. 2012. PMID: 23087749 Free PMC article.
-
Highly sensitive detection of hepatitis B virus surface antigen by use of a semiautomated immune complex transfer chemiluminescence enzyme immunoassay.J Clin Microbiol. 2013 Jul;51(7):2238-44. doi: 10.1128/JCM.00324-13. Epub 2013 May 8. J Clin Microbiol. 2013. PMID: 23658266 Free PMC article.
-
Late HBsAg seroreversion of mutated hepatitis B virus after bone marrow transplantation.BMC Infect Dis. 2013 May 16;13:223. doi: 10.1186/1471-2334-13-223. BMC Infect Dis. 2013. PMID: 23679074 Free PMC article.
-
Impact of Hepatitis B Core Antibody Seropositivity on the Outcome of Autologous Hematopoietic Stem Cell Transplantation for Multiple Myeloma.Biol Blood Marrow Transplant. 2017 Apr;23(4):581-587. doi: 10.1016/j.bbmt.2017.01.005. Epub 2017 Jan 4. Biol Blood Marrow Transplant. 2017. PMID: 28063964 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical